Metrodent

Quick links to important sections

Metrodent

Selected form

Method of action: Antiprotozoal, Disinfectant

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Metrodent

Property Description
Active ingredient Metronidazole and Chlorhexidine Gluconate
Form Dental Gel
Pharmacological Class Combined Antimicrobial Agent
General Purpose Localized oral microbial control
Origin Synthetic

Classification and Core Identity of Metrodent

Metrodent is defined as a specialized fixed-dose combination product, integrating two distinct synthetic active pharmaceutical ingredients for topical application within the oral cavity. It belongs to the Pharmacological class of Combined Antimicrobial Agents, a category developed to address the polymicrobial nature of certain oral infections. Both active components, Metronidazole and Chlorhexidine Gluconate, are established compounds whose dual use in this formulation is clinically recognized for providing enhanced therapeutic coverage, distinguishing it from preparations intended for systemic absorption.

Composition and The Dual-Action Formula

The medicine’s identity is built upon its two primary active ingredients [INN]: Metronidazole and Chlorhexidine Gluconate. Metronidazole is classified as a nitroimidazole derivative, a compound known for effectiveness against anaerobic bacteria, while Chlorhexidine Gluconate is a potent biguanide antiseptic that works by disrupting microbial cell structures. This formulation is prepared as a Dental Gel, a viscous semisolid dosage form with a hydrophilic gel base engineered specifically for localized drug delivery and prolonged contact with the affected oral tissues. The synergistic action resulting from this specific combination allows for a more robust effect than either component provides individually.

General Purpose of this Topical Antimicrobial Agent

The general purpose of the Metrodent formulation is to achieve comprehensive broad-spectrum antibacterial action that is highly localized to the area of concern. By applying two agents with fundamentally different mechanisms of effect, the medicine aims to effectively control a high microbial load, a critical step in managing microbial overgrowth. This makes the topical formulation an intensive support tool intended to assist in managing various oral microbial issues, particularly those associated with the gums and surrounding oral tissues.

Regulatory References

  1. Synergistic Effect of Metronidazole and Chlorhexidine against Porphyromonas gingivalis Growth

What side effects are possible with Metrodent?

Possible Side Effects and Safety Information

The safety characteristics of this topical dental gel are structured by regulatory authorities based on system-organ classes and potential seriousness tiers. Due to the localized application of Metronidazole and Chlorhexidine Gluconate, the adverse effects profile is primarily focused on reactions at the application site.

Documented Adverse Reactions

The most commonly documented adverse reactions are generally mild and localized. These include Gastrointestinal Disorders such as a metallic or bitter taste, transient staining of the teeth or tongue, and nausea. General Disorders and Administration Site Conditions often involve a local burning sensation, irritation, or temporary redness [EFDA SmPC]. These local effects, including taste disturbances and the burning sensation, typically diminish with continued use and are more prominent upon initial application.

Serious Adverse Reactions and Systemic Risks

While systemic absorption is generally low, official labeling documents the possibility of serious adverse reactions associated with the active components. Extremely Rare cases of anaphylaxis and severe hypersensitivity have been reported with the Chlorhexidine component [FDA Safety Communication]. Separately, the Metronidazole component has been associated with peripheral neuropathy (tingling or numbness of extremities) in post-marketing reports for topical formulations [DailyMed Metronidazole Gel Label].

Population and Use Constraints

Specific safety considerations restrict the use of Metrodent in certain populations. The medicine is not recommended for children up to 6 years of age and should not be given during pregnancy or lactation due to safety concerns related to the Metronidazole component [EFDA SmPC]. A high-level safety constraint involves a potential Disulfiram-like effect if alcohol is consumed during treatment or up to 48 hours after discontinuation of the dental gel [EFDA SmPC].

Overdose and Emergency Response

Overdose Manifestations and Complications

The official regulatory profile for Metrodent overdose is defined by the documented risks associated with the systemic absorption of its active components, primarily following accidental or intentional ingestion of large quantities.

Overdose manifestations associated with the Metronidazole component documented in prescribing information include general signs such as nausea, vomiting, and ataxia (impaired coordination). More severe central nervous system effects are officially noted, including the potential for convulsive seizures and the development of peripheral neuropathy. The presence of Chlorhexidine introduces a separate, severe risk: the documented potential for anaphylactic shock or a severe allergic reaction.

Mandated Emergency Action

Regulatory guidance requires prompt action if an overdose is suspected or if signs of a severe allergic reaction occur. Users must seek immediate medical attention for suspected overdose. Furthermore, official communications mandate contacting emergency services immediately upon recognizing signs of a life-threatening reaction such as difficulty breathing or shock.

Treatment is officially described as symptomatic and supportive therapy, as official labeling states that no specific antidote is known for Metronidazole overdose. Due to the potential for serious CNS toxicity, continuous hospital monitoring may be required.

Therapeutic Uses of Metrodent

What Metrodent treats: Main Uses and Benefits

The combined antimicrobial agent is commonly used in situations involving symptoms related to inflammatory or irritative states in the oral cavity. This dental gel is generally used for managing the symptoms of gingivitis and for supportive management of periodontitis, as well as providing focused relief for recurrent aphthous ulceration (mouth sores).

Targeting Key Symptom Clusters

This medication is relevant for addressing symptom clusters that may become intense or disruptive, such as gum swelling, localized redness, and bleeding, which often interfere with daily functioning. It is also considered for managing localized physical discomfort associated with mucosal sores. When applied, the medication may assist with managing symptoms related to inflammatory or irritative states, which can help ease the overall symptom load and contributes to supporting general well-being during symptomatic phases.

The medicine is applied in clinical settings that involve acute or unstable symptom patterns, specifically as an adjunct to professional procedures like scaling and root planing, where supportive symptom management is appropriate. This use supports the patient during difficult episodes by easing distress and contributing to functional stability.

“This supportive action may contribute to easing the localized physical discomfort, which can help patients cope more steadily with symptom fluctuations.”


Quick Fact: Relief for Inflamed Gums Metrodent is commonly used to help ease symptoms related to inflammatory or irritative states in the gums, particularly when redness, swelling, or bleeding are present.

Eligibility and Restrictions for Use

The official eligibility profile for Metrodent (Metronidazole and Chlorhexidine Gluconate Dental Gel) is strictly defined by clear regulatory prohibitions and age-dependent rules. The medicine is generally permitted for use by adults and adolescents 12 years and older.

Eligibility Status Populations as Stated in Official Labeling
Contraindicated Patients with known hypersensitivity to metronidazole, chlorhexidine, or any other ingredient; Women who are pregnant or breastfeeding; Children up to 6 years of age.
Conditional Use Children 6 to 12 years of age (use requires explicit recommendation from a healthcare professional).

Regulatory labeling establishes an absolute prohibition for use in children under six years. Furthermore, use is formally contraindicated during both pregnancy and lactation. Due to the product's topical application and low systemic absorption, official documents do not typically specify eligibility limitations based on organ function, such as severe renal or hepatic impairment.

What should I know about interactions with other medicines?

The official interaction profile for this combination gel primarily reflects the established systemic risks associated with the metronidazole component and the local chemical constraints of the chlorhexidine component.

Property Description
Medicinal product categories with documented interactions: Coumarin anticoagulants; Nitroimidazole derivatives (when used concurrently with Disulfiram).
Specific interacting medicines (if explicitly listed): Disulfiram, Warfarin, conventional dentifrices (containing anionic agents).
Mechanistic basis of interactions (only if stated in label): Pharmacokinetic interaction (potentiation of anticoagulant effect); Local chemical incompatibility; Pharmacodynamic interaction (Disulfiram-like reaction).
Timing-based interaction rules (if applicable): Must not be co-administered with Disulfiram concurrently or within two weeks. Conventional dentifrices containing anionic agents must be separated from gel administration by use before the gel with rinsing, or at a different time of day.
Interaction-related restrictions: Prohibition on co-administration with Disulfiram. Prohibition on the consumption of Alcohol (Ethanol) and alcoholic beverages.

Official Interaction Statements

  • Disulfiram is formally classified as a contraindicated combination because co-administration with the metronidazole component carries the potential for acute conditions of confusion and psychotic reactions. This prohibition extends for two weeks following the cessation of disulfiram.
  • Co-administration with Warfarin and other coumarin anticoagulants may result in a potentiation of the anticoagulant effect, leading to a formal outcome of prolongation of prothrombin time.
  • The medicine has a documented pharmacodynamic interaction with Alcohol (Ethanol) which results in a disulfiram-like reaction. Patients are officially advised to avoid consuming alcoholic beverages during treatment and for a period of up to 48 hours afterward.
  • The chlorhexidine component is incompatible with anionic agents found in many conventional dentifrices. This local interaction requires the application of the dentifrice and the dental gel to be separated in time to maintain the product's efficacy.

Mechanism of Action

The final effect profile is supported by the integration of two distinct pharmacodynamic mechanisms to establish localized microbial load reduction.

Targeted Disruption of Microbial DNA

The nitroimidazole component operates as a prodrug that is activated exclusively within the low-oxygen, high-reductive environment of obligate anaerobic bacteria. This biochemical process generates highly cytotoxic free radicals that attack and fragment the bacterial DNA helix, resulting in the inhibition of nucleic acid synthesis and subsequent bactericidal cell death. This specialized mechanism results in the elimination of target pathogens, which decreases the local microbial source that initiates a host immune response.

️ Physicochemical Cell Membrane Lysis and Sustained Action

The biguanide component acts through a rapid physicochemical mechanism, utilizing its positive charge to bind electrostatically to the negatively charged microbial cell membrane. This binding immediately disrupts the membrane's structural integrity, causing essential cytoplasmic contents to leak out, which leads to rapid cell lysis across a broad spectrum of microorganisms. Crucially, the compound exhibits substantivity, maintaining its adherence to the application site for an extended period, which supports a prolonged reduction of the microbial load.

Synergy of Dual Antimicrobial Pathways

These two distinct mechanisms provide complementary coverage: the biguanide offers immediate, broad-spectrum surface action, while the nitroimidazole targets the deeper-seated anaerobes via a genetic mechanism. This parallel application of membrane-disruption and DNA-fragmentation pathways results in a coordinated reduction of the localized microbial burden, aligning with the expected effect of the combined mechanistic activity.

Dosage and Administration Information

How to Use Metrodent

The usage of Metrodent, a combined metronidazole and chlorhexidine gluconate dental gel, is defined by specific protocols to ensure precise topical application to the oral mucosa.


Administration Scope

Feature Guideline
Route of Administration External oral use only (oromucosal/topical) to the gums and affected tissues.
Dosing Schedule Apply a sufficient amount of gel, typically around one inch (2 cm) when using a toothbrush, directly to the entire affected area.
Frequency Pattern The gel is applied once or twice daily as part of a fixed-duration regimen.
Use Context Constraint The gel is incompatible with conventional anionic toothpastes. Application must be separated in time, or the mouth must be thoroughly rinsed between using the gel and such toothpastes.

Procedural and Duration Guidance

The treatment requires adherence to a specific procedural sequence. The target area must be cleansed prior to application. After the measured amount of gel is applied, the patient is instructed to spit out any excess and not rinse the mouth immediately to maintain contact with the tissue.

Duration and Population Rules
Duration for Gingivitis A standardized course of approximately one month is generally advised.
Duration for Sores/Ulcers Application should be continued for two days after the symptoms have cleared.
Age-Group Rules The standard adult dose is appropriate for older adults and children 12 years and over. The medicine is not used in children under 6 years of age.

This structured approach ensures the localized administration of the product and adherence to the time periods and procedural steps necessary for the intended application.

Recent Clinical Evidence

Research evidence / Overview of Studies for Metrodent


Evidence for Use in Gingivitis (Gum Inflammation)

Research has explored the use of the Metrodent combination gel alongside conventional cleaning procedures in Randomized Controlled Trials (RCTs) focusing on chronic gingivitis. These trials monitored outcomes linked to inflammatory or irritative states, such as changes in gum bleeding, the Gingival Index score, and plaque levels. Findings describe patterns observed in the studies that were compared to placebo or single-component gels. Some comparative research explored whether the combination was associated with differences in the rate of measured changes in these inflammatory markers; however, findings were mixed, with some reporting patterns that did not differ significantly from the Chlorhexidine gel alone.


Evidence for Use as Adjunctive Treatment in Periodontitis

The combination gel was studied for use as a supportive measure in adults with chronic periodontitis, following deep professional cleaning (Scaling and Root Planing, or SRP). Researchers primarily examined outcomes reflecting daily functioning, specifically Probing Pocket Depth (PPD), Clinical Attachment Level (CAL), and ongoing bleeding. The available evidence did not report consistent measured changes regarding key structural markers like PPD across all studies. Systematic reviews noted that measured PPD changes were not always uniformly reported, potentially due to the gel's localized delivery and comparison against sustained-release systems.


Study Scope and Research Uncertainty

The majority of published clinical trials involving the combination gel monitored outcomes over short-term to intermediate periods (up to six months). Consequently, the long-term effects are not fully established regarding the sustained control and durability of these outcomes. Furthermore, the existing clinical research included a primary population of generally healthy adults, meaning data for certain groups remain insufficient. There is limited information regarding observed outcomes in pregnant or lactating females or in patients with complex systemic comorbidities, as these individuals were typically excluded from the primary research.

Key Studies & References

  1. Adjunctive local metronidazole, chlorhexidine or metronidazole plus chlorhexidine to scaling and root planing in the treatment of chronic periodontitis: A systematic review and meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Metrodent (FAQ)


Q: Is it normal to feel a metallic taste after using Metrodent?

According to official product information, a metallic or bitter taste is one of the most commonly reported side effects when using the dental gel. This change in taste is typically described as transient, and it is observed to diminish or resolve upon the completion of the treatment course.


Q: Does Metrodent interact with common pain relievers like ibuprofen?

Regulatory documents list specific drug categories that may interact with this topical product, such as blood thinning medicines or certain stomach ulcer treatments. Common pain relievers like ibuprofen are generally not listed among the documented drug-drug interactions for this specific topical gel formulation.


Q: Can people who have dental implants use Metrodent?

Official public health guidance and clinical data indicate that the active components of this dental gel are commonly used as an adjunct in the maintenance and care surrounding dental work, including dental implants.


Q: What is the typical timeframe for seeing research results from Metrodent studies?

Research documents show that clinical trials involving the combination gel have primarily monitored outcomes over short-term to intermediate periods, typically lasting up to six months. This timeframe is consistent with the product's intended duration of use.


Q: Why might a patient need to stop using Metrodent before the recommended period is over?

Official guidance describes discontinuing treatment when the underlying condition has resolved or if documented serious adverse reactions, such as persistent irritation or nerve issues (peripheral neuropathy), are experienced.


Q: Why do some people report nausea when using Metrodent?

Nausea is officially documented as a common, generally mild, gastrointestinal side effect. This is a known adverse reaction associated with the topical product.


Q: Is it okay to brush my teeth right after applying Metrodent?

Official guidance indicates that the application of the gel and brushing with conventional toothpastes must be separated in time, or the mouth should be thoroughly rinsed between uses, as this separation is required to maintain the product's efficacy.


Q: Can Metrodent affect my sense of taste permanently?

Official safety information indicates that the altered taste sensation and any discoloration of the tongue or teeth are common side effects, but they are considered transient. These effects are expected to resolve after the course of treatment is completed.


Q: Can I take Metrodent if I have a history of liver issues?

Due to the product’s localized application in the mouth and the resulting low systemic absorption, official labels generally do not specify dose adjustments or special warnings based on a history of liver impairment.


Q: Are there any common foods or drinks that interact with Metrodent?

Aside from the specific regulatory restriction requiring avoidance of alcohol and alcoholic beverages during treatment and for a period afterward, official drug-food interactions are not typically documented for this topical formulation.


Q: Can Metrodent cause changes in my tongue or mouth lining?

Documented local reactions include oral irritation, a sensation of dryness in the mouth, and transient discoloration or superficial peeling of the tongue or the inside lining of the mouth.


Q: What happens if I miss a scheduled application of Metrodent?

Official guidance for a missed dose is to apply it as soon as you remember. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped entirely to avoid a double application.


Q: Can Metrodent be used by people who have diabetes?

Diabetes is not officially listed as a contraindication; however, regulatory summaries note that clinical trial data for patients with complex systemic health conditions like diabetes are generally limited.


Q: Why is Metrodent sometimes mentioned alongside a specific dental procedure?

The medicine is classified as an adjunctive treatment, meaning it is designed to be used in addition to professional dental procedures, such as deep cleaning (scaling and root planing). It functions to support localized microbial control after the procedure.


Q: Is Metrodent the same as a mouthwash?

No, Metrodent is formally defined as a dental gel. This is a viscous, semisolid dosage form engineered for targeted application and prolonged contact with the affected oral tissues, distinguishing it from a liquid mouthwash.


Q: Are there studies about Metrodent's long-term use?

Clinical trials have primarily focused on short-term to intermediate periods of up to six months. Official documents state that the long-term effects are not fully established regarding the sustained control and durability of outcomes beyond this intermediate timeframe.


Q: Can Metrodent affect my blood test results?

While systemic absorption is low from the topical application, the metronidazole component, when administered systemically, has been associated with effects on white blood cell counts in clinical data. This is noted in official documentation.


Q: What if I accidentally swallow a small amount of Metrodent?

Official instructions advise spitting out any excess gel after application. Unintentional swallowing of a small amount is not expected to cause harm due to the low systemic exposure, but any large or intentional ingestion should be reviewed by a healthcare professional.


Q: Does the time of day matter when using Metrodent?

The official guidance specifies the required frequency of application, which is typically once or twice daily, but it does not mandate a specific time of day for use.


Q: Can Metrodent cause drowsiness or affect my ability to drive?

Official safety data indicates that, due to the topical application, this product typically does not interfere with a person's ability to drive or operate machinery.


Q: Is there a generic version of Metrodent available?

Yes, the fixed-dose combination of the active ingredients—Metronidazole and Chlorhexidine Gluconate—is widely available from various manufacturers and marketed under different brand names.


Q: Are there any specific official warnings for people with kidney disease about Metrodent?

Official labels generally indicate no special warnings or need for dose adjustments for this topical product in patients with kidney impairment. This is based on the low amount of the medicine that enters the systemic circulation.


Q: Does Metrodent interact with supplements like vitamins or herbal remedies?

Official regulatory documents typically do not contain specific data regarding interactions between this product and non-prescription supplements or herbal remedies. For this reason, consultation regarding concurrent use is generally recommended.


Q: How long does Metrodent stay in my system after the last use?

Due to its topical application, systemic absorption is low. Pharmacokinetic data indicates that peak concentrations of the metronidazole component in the blood are reached within a few hours, and the absorbed amount is subsequently eliminated by the body.


Q: Does Metrodent interfere with fillings or other dental work?

The product is frequently used for oral maintenance around dental work, including crowns, bridges, and implants. Official labels do not generally document a specific chemical incompatibility or interference with standard filling materials.


Q: Can I use Metrodent if I wear dentures or an orthodontic retainer?

Yes, the medicine is used in the context of managing various oral issues. Official public health guidance suggests it can be used by people who wear dental prosthetics like dentures or orthodontic retainers.


Q: What happens if Metrodent is used for longer than the official stated duration?

Regulatory documents state that use exceeding the prescribed duration is associated with an increased occurrence of common local side effects, particularly the transient staining of the teeth and tongue.


Q: Do official documents mention any potential interactions between Metrodent and psychiatric medicines?

Official documents explicitly list a contraindication for the use of the metronidazole component with the drug Disulfiram, which is used for alcohol use disorder. This contraindication is due to the potential for severe reactions involving acute confusion and psychotic symptoms.


Q: Why might Metrodent be considered a 'localized' treatment?

Metrodent is defined as a localized treatment because the gel is specifically designed for topical application directly to the affected area in the mouth. This localized administration is intended to target the site of the issue while resulting in minimal systemic absorption into the rest of the body.


Q: Is the active ingredient in Metrodent commonly used in other medical fields?

Yes, both active ingredients, Metronidazole and Chlorhexidine Gluconate, are well-established compounds. They are commonly used in various other topical and systemic medical treatments for infections and antiseptic purposes in different parts of the body.

How should Metrodent be stored and disposed of?

Storage and Disposal Conditions for Metrodent Dental Gel

Metrodent dental gel must be stored under specific conditions defined in official regulatory labeling to ensure product quality and stability.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F), not exceeding 30 C.
Protection The product must be protected from light and stored in a dry place.
Prohibitions The medicine must not be frozen and must be kept in its original closed container.
Child Safety It is mandatory to store the dental gel out of the sight and reach of children.

Disposal Instructions

Any unused or expired Metrodent dental gel must be handled according to formal guidance. Disposal should be performed in accordance with local pharmaceutical waste requirements to comply with official environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Metrodent found in:

A-Z Index: